NM_172245.4:c.997G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_172245.4(CSF2RA):​c.997G>A​(p.Val333Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000366 in 1,613,180 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 283 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. V333V) has been classified as Benign.

Frequency

Genomes: 𝑓 0.0017 ( 0 hom., 133 hem., cov: 31)
Exomes 𝑓: 0.00022 ( 0 hom. 150 hem. )

Consequence

CSF2RA
NM_172245.4 missense

Scores

1
15

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.81

Publications

0 publications found
Variant links:
Genes affected
CSF2RA (HGNC:2435): (colony stimulating factor 2 receptor subunit alpha) The protein encoded by this gene is the alpha subunit of the heterodimeric receptor for colony stimulating factor 2, a cytokine which controls the production, differentiation, and function of granulocytes and macrophages. The encoded protein is a member of the cytokine family of receptors. This gene is found in the pseudoautosomal region (PAR) of the X and Y chromosomes. Multiple transcript variants encoding different isoforms have been found for this gene, with some of the isoforms being membrane-bound and others being soluble. [provided by RefSeq, Jul 2008]
CSF2RA Gene-Disease associations (from GenCC):
  • surfactant metabolism dysfunction, pulmonary, 4
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • hereditary pulmonary alveolar proteinosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.012759596).
BP6
Variant X-1303973-G-A is Benign according to our data. Variant chrX-1303973-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 537342.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00174 (264/151530) while in subpopulation AFR AF = 0.0062 (256/41296). AF 95% confidence interval is 0.00558. There are 0 homozygotes in GnomAd4. There are 133 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 133 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CSF2RANM_172245.4 linkc.997G>A p.Val333Met missense_variant Exon 11 of 13 ENST00000381529.9 NP_758448.1 P15509-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CSF2RAENST00000381529.9 linkc.997G>A p.Val333Met missense_variant Exon 11 of 13 1 NM_172245.4 ENSP00000370940.3 P15509-1

Frequencies

GnomAD3 genomes
AF:
0.00174
AC:
264
AN:
151412
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00622
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000330
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00145
GnomAD2 exomes
AF:
0.000406
AC:
102
AN:
251182
AF XY:
0.000317
show subpopulations
Gnomad AFR exome
AF:
0.00554
Gnomad AMR exome
AF:
0.000202
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000881
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000224
AC:
327
AN:
1461650
Hom.:
0
Cov.:
30
AF XY:
0.000206
AC XY:
150
AN XY:
727128
show subpopulations
African (AFR)
AF:
0.00807
AC:
270
AN:
33472
American (AMR)
AF:
0.000224
AC:
10
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000696
AC:
6
AN:
86250
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5762
European-Non Finnish (NFE)
AF:
0.0000171
AC:
19
AN:
1111824
Other (OTH)
AF:
0.000364
AC:
22
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
18
36
55
73
91
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00174
AC:
264
AN:
151530
Hom.:
0
Cov.:
31
AF XY:
0.00180
AC XY:
133
AN XY:
73982
show subpopulations
African (AFR)
AF:
0.00620
AC:
256
AN:
41296
American (AMR)
AF:
0.000330
AC:
5
AN:
15174
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3464
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5080
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4758
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10520
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67936
Other (OTH)
AF:
0.00143
AC:
3
AN:
2096
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
10
19
29
38
48
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Bravo
AF:
0.00209
ESP6500AA
AF:
0.00545
AC:
24
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000478
AC:
58

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Feb 21, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Val333Met in exon 12 of CSF2RA: This variant is not expected to have clinical si gnificance because it has been identified in 0.5% (24/4406) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS; dbSNP rs150290042). -

Surfactant metabolism dysfunction, pulmonary, 4 Benign:1
Dec 24, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.73
T
BayesDel_noAF
Benign
-0.82
CADD
Benign
0.38
DANN
Benign
0.74
DEOGEN2
Benign
0.16
T;.;.;T;T;.
FATHMM_MKL
Benign
0.00098
N
LIST_S2
Benign
0.56
.;T;T;.;T;T
M_CAP
Benign
0.011
T
MetaRNN
Benign
0.013
T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.0
L;.;.;L;L;L
PhyloP100
-1.8
PrimateAI
Benign
0.44
T
PROVEAN
Benign
-0.11
N;N;N;N;N;N
REVEL
Benign
0.012
Sift
Benign
0.069
T;T;D;T;T;T
Sift4G
Uncertain
0.037
D;D;D;D;D;D
Polyphen
0.0020
B;.;.;B;B;B
Vest4
0.25
MVP
0.31
MPC
0.12
ClinPred
0.00073
T
GERP RS
-1.6
Varity_R
0.042
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs150290042; hg19: chrX-1422866; COSMIC: COSV100817561; COSMIC: COSV100817561; API